RxSight, Inc. (NASDAQ:RXST) Receives $49.33 Average Target Price from Analysts
RxSight, Inc. (NASDAQ:RXST – Get Free Report) has been assigned an average rating of “Moderate Buy” from the nine brokerages that are presently covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and six have given a buy rating to […]
